HEMLIBRA

Solution for injection, 300mg/2ml
RxActive license

Active substance (INN)

emicizumab

Pharmaceutical form

Pharmaceutical formSolution for injection
Strength300mg/2ml
PackagingUkupno 1 bočica staklena sa 2ml rastvora za injekciju
ManufacturerF. Hoffmann-La Roche AG, Switzerland
Therapeutic groupBlood and blood forming organs (B02BX06)
Marketing authorization holder"Hoffmann-La Roche LTD" D.S.D. Podgorica
Authorization dateFebruary 3, 2025

Analogs in Montenegro

5

Other medicines with the same active substance

HEMLIBRARx
Solution for injection, 12mg/0.4mlF. Hoffmann-La Roche AG
HEMLIBRARx
Solution for injection, 30mg/mlF.Hoffmann-La Roche Ltd.
HEMLIBRARx
Solution for injection, 60mg/0.4mlF.Hoffmann-La Roche Ltd.
HEMLIBRARx
Solution for injection, 105mg/0.7mlF.Hoffmann-La Roche Ltd.
HEMLIBRARx
Solution for injection, 150mg/mlF.Hoffmann-La Roche Ltd.
Source: CInMED register